Tuesday, July 20, 2021 10:10:24 AM
The turning point of this company was when they did not sell their cream on the open market to start receiving revenue. Who the hell knows what their plan actually was but there was considerable amount of time and effort placed on filing for FDA approval in many countries including USA.
The cream and sublingual tablet would have been two products where licensing deals could make more than them trying to sell it themselves. It's all about their proprietary ingredients and they blew it.
Who knows what's in-store for this ticker but in a few months, with new SEC rules, it can't be bought with the usual brokers.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM